ALL vs ALNY · P/E 4.9, rev $18.60B vs P/E 76, rev $1.29B
The Allstate Corporation (ALL) versus Alnylam Pharmaceuticals Inc (ALNY) — a side-by-side from cached financials, not a winner call.
The Allstate Corporation (ALL) is a insurance - property & casualty company listed on US.
Alnylam Pharmaceuticals Inc (ALNY) is a biotechnology company listed on US.
Latest reported ALL revenue for 2026-06-30 was $18.60B. Net income was $3.27B. Revenue was up 9.8% from 2026-03-31 to 2026-06-30. ALL currently screens at market cap $56.89B and trailing P/E 4.9.
Latest reported ALNY revenue for 2026-06-30 was $1.29B. Net income was $164.5M. Revenue was up 3.4% from 2025-09-30 to 2026-06-30. ALNY currently screens at market cap $40.46B and trailing P/E 76.3.
ALL currently screens at market cap $56.89B and trailing P/E 4.9. ALNY currently screens at market cap $40.46B and trailing P/E 76.3.
Not investment advice. Open the ALL and ALNY stock pages for the full models.
Not investment advice.